NBDF showcases a wide array of findings from the latest in bleeding disorders research at our annual Bleeding Disorders Conference.
Stepping Up and Reaching Out to the Community
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Peer Support/Outreach/Integration Models
Preclinical Research with Recombinant Factor VIIa Fusion Proteins with Enhanced In vitro Activity and Improved Half-Life in Mice
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Biomedical/Coagulation Research
Speaking Frankly to Young Adults with Hemophilia
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Peer Support/Outreach/Integration Models
Prevalence and Predictors of Food Insecurity in Children with Hemophilia
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Clinical Research
Collaborative partnership helps resolve cultural barriers in patient receiving continuous infusion of factor (ACAT Protocol) in the home setting
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Collaboration/Team Models
Factor for Felons; Management of Incarcerated Hemophiliacs
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Psychosocial Issues
Prospective Clinical Trial of a Novel Recombinant Factor IX in Previously Treated Patients
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Clinical Research
Atrial Fibrillation in People with Hemophilia: a Cross-Sectional Evaluation in Europe by the ADVANCE Working Group
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Biomedical/Coagulation Research
The influence of co-morbidities on annualized bleeding rates in patients with severe hemophilia A: experiences from the pivotal turoctocog alfa prophylaxis trial (guardianTM1)
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Clinical Research
A Phase I Study of Safety and Pharmacokinetics of BAX 855, a Longer Acting PEGylated Full-Length Recombinant Factor VIII (PEG-rFVIII), in Patients with Severe Hemophilia A
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Clinical Research
The cytokine storm which follows joint bleeding: identifying a plasma signature of joint bleeding
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Biomedical/Coagulation Research
Preclinical PK/PD Characteristics of rVIII-SingleChain, a Novel Recombinant Single-Chain FVIII
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Biomedical/Coagulation Research
Patient, Caregiver, and Nurse Satisfaction with BAXJECT III, a Next-Generation Reconstitution System for AHF-rFVIII (ADVATE®)
AWARDED/PRESENTED: 2013
GRANT/PROGRAM:
Bleeding Disorders Conference
Psychosocial Issues